MY133368A - Process for preparing pharmaceutical compositions for use with soft gelatin formulations - Google Patents
Process for preparing pharmaceutical compositions for use with soft gelatin formulationsInfo
- Publication number
- MY133368A MY133368A MYPI20014820A MYPI20014820A MY133368A MY 133368 A MY133368 A MY 133368A MY PI20014820 A MYPI20014820 A MY PI20014820A MY PI20014820 A MYPI20014820 A MY PI20014820A MY 133368 A MY133368 A MY 133368A
- Authority
- MY
- Malaysia
- Prior art keywords
- active ingredient
- pharmaceutically active
- concentration
- soft gelatin
- pharmaceutical compositions
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
THE INVENTION DISCLOSED HEREIN IS A PROCESS FOR INCREASING THE ACHIEVABLE CONCENTRATION OF A PHARMACEUTICALLY ACTIVE INGREDIENT RELATIVE TO FILL COMPOSITION VISCOSITY FOR DOSAGE UNITS. THE PROCESS IS PARTICULARLY USEFUL IN THE PREPARATION OF SOFT GELATIN CAPSULES CONTAINING IBUPROFEN, NAPROXEN, INDOMETHACIN, AND ACETAMINOPHEN, AS THE PHARMACEUTICALLY ACTIVE INGREDIENT. AS A RESULT OF THE PROCESS, LESSER QUANTITIES OF COMPOSITION INGREDIENTS OTHER THAN THE PHARMACEUTICALLY ACTIVE INGREDIENT ARE NEEDED TO ACCOMPLISH THE SAME THERAPEUTICALLY EFFECTIVE DOSAGE, THEREBY SIGNIFICANTLY INCREASING THE CONCENTRATION OF THE PHARMACEUTICALLY ACTIVE INGREDIENT RESULTING IN EITHER A REDUCTION IN OVERALL FILL VOLUME AND DOSAGE UNIT SIZE OR AN INCREASE IN CONCENTRATION OF PHARMACEUTICALLY ACTIVE INGREDIENT PER DOSAGE FORM.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20014820A MY133368A (en) | 2001-10-17 | 2001-10-17 | Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20014820A MY133368A (en) | 2001-10-17 | 2001-10-17 | Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY133368A true MY133368A (en) | 2007-11-30 |
Family
ID=78573158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20014820A MY133368A (en) | 2001-10-17 | 2001-10-17 | Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY133368A (en) |
-
2001
- 2001-10-17 MY MYPI20014820A patent/MY133368A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2431702A (en) | Process for preparing pharmaceutical compositions for use with soft gelatin formulations | |
| MY118371A (en) | Tetrahydrolipstatin containing compositions | |
| GEP20063741B (en) | Nonaryl-Heterocyclic NMDA/NR2B Antagonists | |
| GEP20022851B (en) | Flash-Melt Oral Dosage Formulation | |
| CA2251886A1 (en) | An oral pharmaceutical formulation containing ibandronate | |
| IL158668A0 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
| HK1067299A1 (en) | Pharmaceutical compositions containing terbinafineand use thereof | |
| HUP0301390A2 (en) | Oral pharmaceutical composition containing valsartan | |
| WO2002024203A3 (en) | Controlled release formulations for oral administration | |
| HUP0004363A2 (en) | Solid pharmaceutical compositions containing miltefosine for use in the treatment of leishmaniasis | |
| MXPA04004907A (en) | Acetaminophen compositions. | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| MY133368A (en) | Process for preparing pharmaceutical compositions for use with soft gelatin formulations | |
| CA2356306A1 (en) | Sulfated phosphatidylinositols, their preparation and use | |
| KR960700701A (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING PARACETAMOL AND L-CYSTEINE OR A PRECURSOR THEREOF | |
| DE69800210D1 (en) | Anhydrous lactulose-based product | |
| AU2019203288A1 (en) | Process for preparing pharmaceutical compositions resulting in reduction in overall fill volume for use with soft gelatin formulations | |
| HUP0100634A2 (en) | Pharmaceutical preparations comprising pentaerytritol tetranitrate | |
| MY145885A (en) | Controlled release formulations for oral administration | |
| NO964775L (en) | Solid pharmaceutical adenosine-containing preparation | |
| DE50311479D1 (en) | PHARMACEUTICAL COMPOSITION, CONTAINING OXCARBAZEPINE WITH CONTROLLED ACTIVE INGREDIENTS |